pTINCR Expression Is Associated with Tumor Aggressiveness but Does Not Independently Predict Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198443 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Raquel Santos-Juanes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Service, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Skin Neoplasms, RNA, Long Noncoding, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Cáncer, Agency for Science, Business Competitiveness and Innovation of the Principado de Asturias.
Abstract (Originalsprache)
Terminal differentiation-induced non-coding RNA (TINCR), initially classified as a long non-coding RNA, encodes a biologically active microprotein (pTINCR) involved in epidermal differentiation and tumor biology. However, the clinicopathological and prognostic relevance of pTINCR expression in cutaneous squamous cell carcinoma (cSCC) remains unclear. We conducted a retrospective case–control study including 116 patients with head and neck cSCC: 58 patients who developed nodal metastasis and 58 non-metastatic controls. pTINCR expression was assessed by immunohistochemistry and analyzed in relation to clinicopathological characteristics and clinical outcomes. Unconditional logistic regression was used to evaluate its association with nodal metastasis. Cox proportional hazards models were additionally used to explore associations with time-to-event outcomes. Negative pTINCR expression was significantly associated with tumor thickness > 6 mm (p < 0.001), poorer histological differentiation (p = 0.002), and higher tumor stage (p = 0.011). In univariate logistic regression, negative pTINCR expression was associated with higher odds of nodal metastasis (OR 2.71, 95% CI 1.27–5.77; p = 0.010), but this association was no longer significant after adjustment for established clinicopathological factors (adjusted OR 1.25, 95% CI 0.34–4.59; p = 0.736). In Cox analyses, negative pTINCR expression was associated with a shorter time to nodal metastasis (HR 1.88; p = 0.017) and higher tumor-specific mortality (HR 2.02; p = 0.033) in univariate analyses, but not after multivariable adjustment. Tumor budding remained the strongest independent prognostic factor across the evaluated time-to-event outcomes. Loss of pTINCR expression is associated with adverse histopathological features and nodal metastasis in head and neck cSCC, but it does not provide independent prognostic information beyond established clinicopathological factors. pTINCR may therefore serve as a marker of an aggressive tumor phenotype rather than an independent prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Service, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
- Dermatology Area, Department of Medicine, University of Oviedo, 33006 Oviedo, Spain.
- Grupo de Investigación en Dermatología (GRIDER), Universidad de Oviedo, 33006 Oviedo, Spain.
- Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011 Oviedo, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.
ORCID-Profile: Raquel Santos-Juanes, Jorge Santos-Juanes, Noelia Blanco-Agudín, Juana M García-Pedrero, Juan P Rodrigo, Iván Fernández-Vega
Förderung
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Cáncer
- Agency for Science, Business Competitiveness and Innovation of the Principado de Asturias
- Agencia de Ciencia del Principado de Asturias
- CIBERONC
- Instituto de Investigación Sanitaria del Principado de Asturias
- Fundación Bancaria Caja de Ahorros de Asturias-IUOPA
- Universidad de Oviedo
Zitieren
APA
Santos-Juanes, R., Santos-Juanes, J., Blanco-Agudín, N., Merayo-Lloves, J., Vivanco, B., García-Pedrero, J. M., Rodrigo, J. P., Fernández-Vega, I., & Galache, C. (2026). pTINCR Expression Is Associated with Tumor Aggressiveness but Does Not Independently Predict Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198443
Vancouver
Santos-Juanes R, Santos-Juanes J, Blanco-Agudín N, Merayo-Lloves J, Vivanco B, García-Pedrero JM, et al. pTINCR Expression Is Associated with Tumor Aggressiveness but Does Not Independently Predict Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198443
BibTeX
@article{SantosJuanes2026,
author = {Santos-Juanes, Raquel and Santos-Juanes, Jorge and Blanco-Agudín, Noelia and Merayo-Lloves, Jesús and Vivanco, Blanca and García-Pedrero, Juana M and Rodrigo, Juan P and Fernández-Vega, Iván and Galache, Cristina},
title = {pTINCR Expression Is Associated with Tumor Aggressiveness but Does Not Independently Predict Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198443}
}
EUVIMED